NCT00891852Unknown不适用
Non-Invasive Determination of Fetal Chromosome Abnormalities
Lenetix Medical Screening Laboratory7 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2009年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,000
- 试验地点
- 7
研究概览
简要总结
The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •This study is only applicable to women who are between 8 and 30 weeks' gestation and who have been determined increased risk for fetal aneuploidy. In the interest of expediting and simplifying this study, the investigators want only women who have already decided to undergo second-trimester amniocentesis or CVS.
排除标准
- •The only exclusion criteria are those mentioned.
研究者
研究点 (7)
Loading locations...
相似试验
已完成
不适用
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected PregnanciesDown SyndromeAneuploidyNCT01052688Sequenom, Inc.150
已完成
不适用
Non-Invasive Screening for Fetal AneuploidyDown SyndromeEdwards SyndromeNCT00847990Sequenom, Inc.5,000
已完成
不适用
Non-Invasive Chromosomal Evaluation of 22q11.222q.11.2 Deletion/DuplicationNCT02541058Cindy Cisneros420
招募中
不适用
Non-invasive Placental Chromosome Exploration of Intrauterine Growth RestrictionFetal Growth RetardationNCT05023161University Hospital, Bordeaux300
Unknown
不适用
Non-Invasive Screening for Fetal AneuploidyDown SyndromeEdwards SyndromeNCT02317965Progenity, Inc.340